Three-year results of denosumab treatment for osteoporosis in women with rheumatoid arthritis and primary osteoporosis: A clinical observational study-Reference-Cited by-同舟云学术

Three-year results of denosumab treatment for osteoporosis in women with rheumatoid arthritis and primary osteoporosis: A clinical observational study

Published:2020-09-10 Issue:3 Volume:31 Page:600-606
ISSN:1439-7595
Container-title:Modern Rheumatology
language:en
Short-container-title:Modern Rheumatology

Author:

Mochizuki Takeshi¹^ORCID,Yano Koichiro²^ORCID,Ikari Katsunori²^ORCID,Hiroshima Ryo¹^ORCID,Nasu Yuki¹,Okazaki Ken²^ORCID

Affiliation:

1. Department of Orthopaedic Surgery, Kamagaya General Hospital, Chiba, Japan

2. Department of Orthopaedic Surgery, Tokyo Women’s Medical University, Tokyo, Japan

Publisher

Oxford University Press (OUP)

Subject

Rheumatology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14397595.2020.1812793

Reference40 articles.

1. Quality of life in rheumatoid arthritis

2. Work disability in rheumatoid arthritis is predicted by physical and psychological health status: a 7‐year study from the Oslo RA register

3. Effects of an educational–behavioral joint protection program on people with moderate to severe rheumatoid arthritis: a randomized controlled trial

4. Rheumatoid arthritis

5. Mechanisms of Disease: the link between RANKL and arthritic bone disease

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of Locomotion Training on Bone Mineral Density in Patients with Rheumatoid Arthritis;Progress in Rehabilitation Medicine;2024

2. Cut-off values for achieving osteoporosis treatment goals in women with rheumatoid arthritis receiving denosumab;Modern Rheumatology;2022-12-09

3. Osteoporosis evaluation and treatment recommendations in rheumatoid arthritis;Best Practice & Research Clinical Rheumatology;2022-09

4. Comparison of romosozumab versus denosumab treatment on bone mineral density after 1 year in rheumatoid arthritis patients with severe osteoporosis: A randomized clinical pilot study;Modern Rheumatology;2022-06-11

5. Donesumab;Reactions Weekly;2022-04